![]() |
![]() |
|
|
|
IN THIS ARTICLE ![]()
If your diet is deficient in iron, calcium, zinc or phosphate, you are more susceptible to lead poisoning. more...![]() OTHER TOPICS ![]() |
Male Menopause John E. Morley, M.D. A 73-year-old man fell while on a walking tour in the Venezuelan Andes. He was going up a relatively steep, rocky incline when he lost his footing and fell forward. He did not fracture any bones, but, on returning to the U.S.A., decided to consult his physician concerning a general decrease in strength that had affected, among other things, his tennis game. The man, we'll call him Mr. B, also reported that he was often mildly fatigued, more grumpy than in the past, had diminished enthusiasm for sex and was less excited about planning future travel. Does this remind you of anyone you know? In a younger person, below age 50, an emotional explanation, such as mild depression or family problems, would probably account for his complaints but, because he was well past 50 and had reported a decreased interest in sex, low testosterone syndrome was considered. Here are Mr. B's answers to the St. Louis University Low Testosterone Syndrome Survey:
The Low Testosterone Syndrome As is shown in Figure 1, nearly half of healthy males over 50 years of age have testosterone levels less than those seen in normal young males.1 ![]() Figure 1 Statistical studies have suggested the following effects may be associated with decline in testosterone:
Testosterone replacement is the standard treatment. Studies have shown increased strength,3,4,5 improved visual spatial thinking,6 increased bone and lean body mass7 and decreased levels of leptin (the fat hormone).6 The major side effect of testosterone therapy is an increase in the percentage of red blood cells (the hematocrit) in the blood. People with too thick blood run the risk of blood clots and other mechanical blockages, especially in the smaller arteries and veins. When the hematocrit is more than 55%, testosterone needs to be discontinued or the patient has to have a blood letting. Hematocrit should be followed every three months. Other side effects include:
However, evidence from available studies suggests that testosterone does not worsen benign prostatic enlargement in older men and has no effect, one way or the other, on blood cholesterol levels. Methods of Testosterone Administraton Most often, testosterone is adminstered intramuscularly. Usually 200 mg of testosterone enanthate or cypionate is given every two weeks. Patients can be taught to self-inject at home. Two testosterone patches are available. Testoderm® is placed on the shaved scrotum, while Androderm® is placed directly on the skin. Androderm® has a high rate of skin allergies and both patches are much more expensive than the injections. In Canada and Europe, testosterone undecenoate (Organon®) is an oral preparation that is absorbed through the lymph channels, making it less damaging to the liver than other orally available forms of testosterone. Finally, intramuscular implantation of testosterone pellets represents a depot delivery system. Conclusion The potential of testosterone therapy of the male meno(viro)pause is outlined in Figure 2: ![]() Figure 2
References 1. Morley JE, Garry PJ. Longitudinal fall in testosterone. Metabolism 46:410-413, 1997. return 2. Schiavi RC, Schreiner-Engel P, White D, Mandeli J. The relationship between pituitary-gonadal function and sexual behavior in healthy aging men. Psychosom Med 53:363-74, 1991. return 3. Morley JE, Perry HM 3d, Kaiser FE, Kraenzle D, Jensen J, Houston K, Mattammal M, Perry HM Jr. Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41:149-52, 1993. return 4. Urban RJ, Bodenberg YH, Gilkison C, Foxworth J, Coggan AR, Wolfe RR, Ferrando A. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol 269:E820-6, 1995. return 5. Sih R, Morley JE, Kaiser FE et al. Effects of one year testosterone therapy. J Clin Endocrinol Metab 82:1661-1667, 1997. return 6. Janowsky JS, Oviatt SK, Orwoll ES. Testosterone influences spatial cognition in older men. Behav Neurosci 108:325-32, 1994. return 7. Reid IR, Wattie DJ, Evans MC, Stapleton JP. Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173-7, 1996. return |
|||||
|
|
|
|
||||
|
NEWS SEARCH CONTENTS MEDITORIAL ASK DISCUSS REGISTER HELP HOME |
||||||
© 2008 interMDnet Corporation. All Rights Reserved. PRIVACY POLICY |
||||||